IDT · ASX

IDT Australia Limited (ASX:IDT)

AU$0.1

 -0.005 (-4.762%)
ASX:Live
21/11/2024 04:10:42 PM
HALO Ords GROWTH AUS Engulfing Bearish All-Consensus All-Companies
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

IDT Overview

IDT Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Neutral

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Neutral

Balance Sheet

Very Strong

About IDT

Telephone

Address

Description

IDT Australia Ltd. produces, develops and supplies pharmaceutical products. It engages in the provision of research and development and other technical services for the pharmaceutical and allied industries. The company specializes in the post-discovery pharmaceutical life cycle. It also provides services through API manufacturing, new drug development and scale-up, clinical research services, pharmacy services and finished dosage forms to the pharmaceutical industry. IDT Australia was founded by Graeme Leslie Blackman on October 14, 1975 and is headquartered in Melbourne, Australia.

IDT Price Chart

Key Stats

Market Cap

AU$42.98M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.08 - 0.14

Trade Value (12mth)

AU$8,227.00

1 week

0%

1 month

-16%

YTD

-2%

1 year

26.82%

All time high

2.80

Key Fundamentals

EPS 3 yr Growth

-280.20%

EBITDA Margin

-44.80%

Operating Cashflow

-$10m

Free Cash Flow Return

-40.40%

ROIC

-22.80%

Interest Coverage

-49.80

Quick Ratio

1.10

Other Data

Shares on Issue (Fully Dilluted)

357m

HALO Sector

Next Company Report Date

02-Sep-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

IDT Announcements

Latest Announcements

Date Announcements

19 November 24

2024 AGM Presentation

×

2024 AGM Presentation

19 November 24

AGM Results of Meeting

×

AGM Results of Meeting

13 November 24

Termination of discussions with Mynd

×

Termination of discussions with Mynd

21 October 24

Q1 FY25 Quarterly Unaudited Revenue Hits Two-Year High

×

Q1 FY25 Quarterly Unaudited Revenue Hits Two-Year High

18 October 24

Notice of Annual General Meeting

×

Notice of Annual General Meeting

10 September 24

Notification regarding unquoted securities - IDT

×

Notification regarding unquoted securities - IDT

09 September 24

Application for quotation of securities - IDT

×

Application for quotation of securities - IDT

26 August 24

FY24 Appendix 4E and Annual Report

×

FY24 Appendix 4E and Annual Report

26 August 24

FY24 Appendix 4G and Corporate Governance Statement

×

FY24 Appendix 4G and Corporate Governance Statement

26 August 24

FY24 Full Year Profit Results

×

FY24 Full Year Profit Results

26 August 24

FY24 Full Year Results Presentation

×

FY24 Full Year Results Presentation

09 August 24

IDT Secures New Contract with Sanofi Australia

×

IDT Secures New Contract with Sanofi Australia

30 July 24

Strong Q4 Pushes Full-Year Revenue Ahead of Guidance

×

Strong Q4 Pushes Full-Year Revenue Ahead of Guidance

10 July 24

Completion of Entitlement Offer

×

Completion of Entitlement Offer

10 July 24

Application for quotation of securities - IDT

×

Application for quotation of securities - IDT

10 July 24

Change in substantial holding from SNC

×

Change in substantial holding from SNC

27 June 24

Reminder of IDT Entitlement Offer Closing Date

×

Reminder of IDT Entitlement Offer Closing Date

13 June 24

IDT Despatches Entitlement Offer Booklet

×

IDT Despatches Entitlement Offer Booklet

11 June 24

Update on Indicative Proposal from Mynd

×

Update on Indicative Proposal from Mynd

05 June 24

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

04 June 24

Entitlement Offer to Raise $7m

×

Entitlement Offer to Raise $7m

04 June 24

Proposed issue of securities - IDT

×

Proposed issue of securities - IDT

04 June 24

Cleansing Notice

×

Cleansing Notice

04 June 24

Correction - Entitlement Offer To Raise $7m at 9c Per Share

×

Correction - Entitlement Offer To Raise $7m at 9c Per Share

04 June 24

Update - Proposed issue of securities - IDT

×

Update - Proposed issue of securities - IDT

IDT Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.00 -0.03 -0.02 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.00 -0.03 -0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock -154.7 -621.3 54.3 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.01 -0.03 -0.02 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock 0.01 -0.03 -0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock 30.5 -211.3 51.6 Lock Lock Lock
     Yield % Lock Lock Lock Lock 7.0 -53.1 -26.9 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.11 0.08 0.07 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.11 0.08 0.07 Lock Lock Lock
     Growth % Lock Lock Lock Lock -3.2 -28.3 -15.6 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 247 251 348 Lock Lock Lock
Basic m Lock Lock Lock Lock 247 251 348 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 12 7 13 Lock Lock Lock
     Growth % Lock Lock Lock Lock -24.3 -42.7 90.7 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 5 6 7 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 3 -4 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock -42.2 -225.2 99.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock 23.3 -50.9 -0.1 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 77 151 100 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 0 -9 -6 Lock Lock Lock
     Growth % Lock Lock Lock Lock -112.4 -2,469.7 32.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -2.8 -126.0 -44.8 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 2 1 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -2 -10 -7 Lock Lock Lock
     Growth % Lock Lock Lock Lock -294.2 -421.1 29.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -15.5 -141.0 -51.8 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -2 -10 -7 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -1 -1 -1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -1 -8 -5 Lock Lock Lock
     Growth % Lock Lock Lock Lock -155.2 -632.6 36.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -9.6 -122.5 -40.9 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 3 -8 -10 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -1 -1 -1 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 0 4 7 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 2 -8 -10 Lock Lock Lock
     Growth % Lock Lock Lock Lock 1,349.4 -532.2 -22.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.2 -1.2 -0.8 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 9 4 1 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 30 28 31 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -8 -4 4 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 3 4 8 Lock Lock Lock
Equity $m Lock Lock Lock Lock 27 24 23 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 27 24 23 Lock Lock Lock
     Growth % Lock Lock Lock Lock -3.6 -9.3 -2.9 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -3.9 -30.0 -17.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -4.4 -35.2 -23.1 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -6.7 -37.1 -26.0 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -4.3 -33.2 -22.8 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 10.5 -30.9 -40.4 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock N/A N/A -49.8 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 24.5 0.4 -0.7 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -31.3 -15.3 16.9 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 4.4 2.4 1.3 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 4.1 2.1 1.1 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 66.5 45.5 4.8 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 91.1 -198.4 -123.8 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 2.2 2.7 2.8 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 11.9 8.5 8.7 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 1.1 1.2 5.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 4.5 5.0 5.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.4 0.2 0.4 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.4 0.2 0.4 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -15.5 -141.0 -50.0 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -6.2 -34.6 -21.1 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -3.9 -30.0 -17.3 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.2 1.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -4.4 -35.2 -23.1 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -4.4 -35.2 -23.1 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 30.6 43.1 42.1 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 165.2 135.8 130.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 195.8 178.9 172.1 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 61.6 15.2 13.6 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 134.2 163.7 158.5 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

IDT Shortsell

Frequently Asked Questions

The current share price of IDT Australia Limited (IDT:ASX) is AU$0.1.
The 52-week high share price for IDT Australia Limited (IDT:ASX) is AU$0.14.
The 52-week low share price for IDT Australia Limited (IDT:ASX)? is AU$0.08.
IDT Australia Limited (IDT:ASX) does not pay a dividend.
The last dividend payment of IDT Australia Limited (IDT:ASX) is AU$0.01.
IDT Australia Limited (IDT:ASX) has a franking level of 0.0%.
IDT Australia Limited (IDT:ASX) is classified in the Healthcare.
The current P/E ratio for IDT Australia Limited (IDT:ASX) is .